Cheap HIV Drug for DME, study
May 29, 2025

Oral Lamivudine Shows Vision Gains in DME Patients in Early Clinical Trial

Low-cost HIV drug improves visual acuity in diabetic macular edema A decades-old HIV drug is showing fresh promise for a…

unnamed_(4)
May 28, 2025

iCare at APAO 2025: Dr. Malvika Gupta on EIDON High Resolution Retinal Imaging Device

At APAO 2025, Dr. Malvika Gupta (India) shares how iCare’s EIDON sets a new standard in high quality retina imaging—combining…

popular posts
The Potential for Better and Faster Drying with Longer Treatment Intervals Experts share how aflibercept 8 mg could reshape clinical practice (1)
May 13, 2025

The Potential for Better and Faster Drying with Longer Treatment Intervals

Thiết kế chưa có tên (15)
May 13, 2025

Aflibercept 8mg Has Been Available for Over a Year. Here’s What nAMD Experts Are Saying About Early Experiences. 

Article 1 Day 1_ ARVO
May 6, 2025

Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work

latest posts
Cheap HIV Drug for DME, study
May 29, 2025

Oral Lamivudine Shows Vision Gains in DME Patients in Early Clinical Trial

unnamed_(4)
May 28, 2025

iCare at APAO 2025: Dr. Malvika Gupta on EIDON High Resolution Retinal Imaging Device

The Potential for Better and Faster Drying with Longer Treatment Intervals Experts share how aflibercept 8 mg could reshape clinical practice (1)
May 13, 2025

The Potential for Better and Faster Drying with Longer Treatment Intervals

Thiết kế chưa có tên (15)
May 13, 2025

Aflibercept 8mg Has Been Available for Over a Year. Here’s What nAMD Experts Are Saying About Early Experiences. 

Web Day 3
May 7, 2025

ARVO 2025 Day 3: Genetics Deep Dive, Adaptive Optics and Award-Winning Regenerative RP Tech

Article_1_Day_3_ARVO
May 7, 2025

Seeing the Unseen: Adaptive Optics Enters the Clinical Arena at ARVO 2025

Article 1 Day 1_ ARVO
May 6, 2025

Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work

FDA Rejects Regeneron’s Bid to Extend EYLEA HD Dosing Beyond 16 Weeks
April 22, 2025

FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval

Discover our fascinating content at issuu

explore